These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 2684594)

  • 1. Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.
    Merritt TA; Hallman M; Spragg R; Heldt GP; Gilliard N
    Drugs; 1989 Oct; 38(4):591-611. PubMed ID: 2684594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL; Faulds D
    Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant: clinical applications.
    Patton CD; Schulman ES
    Am Fam Physician; 1992 Jul; 46(1):233-6. PubMed ID: 1621634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant: current and potential therapeutic application in infants and adults.
    Lewis J; Veldhuizen RA
    J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
    Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
    Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
    Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.
    Walti H; Monset-Couchard M
    Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bases of the replacement surfactant therapy for bronchopulmonary diseases].
    Zagorul'ko AK; Kliaritskaia IL
    Lik Sprava; 2004; (5-6):79-86. PubMed ID: 15605831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives for use of surfactant in children and adults.
    Marraro GA
    J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():29-31. PubMed ID: 15590431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous surfactant in acute respiratory distress syndrome: more is better.
    Anzueto A
    Eur Respir J; 2002 May; 19(5):787-9. PubMed ID: 12030713
    [No Abstract]   [Full Text] [Related]  

  • 12. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous surfactant therapy in newborn infants.
    Suresh GK; Soll RF
    Ann Acad Med Singap; 2003 May; 32(3):335-45. PubMed ID: 12854377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.